BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 6640389)

  • 1. Topical silver sulphadiazine: side effects and urinary excretion.
    Lockhart SP; Rushworth A; Azmy AA; Raine PA
    Burns Incl Therm Inj; 1983 Sep; 10(1):9-12. PubMed ID: 6640389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical silver sulphadiazine and profound neutropenia in a burned child.
    Wilson P; George R; Raine P
    Burns Incl Therm Inj; 1986 Apr; 12(4):295-6. PubMed ID: 3719408
    [No Abstract]   [Full Text] [Related]  

  • 3. Absorption, excretion and tissue distribution of silver sulphadiazine.
    Sano S; Fujimori R; Takashima M; Itokawa Y
    Burns Incl Therm Inj; 1982 Mar; 8(4):278-85. PubMed ID: 7066727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum and urinary silver levels in thermal injury patients.
    Boosalis MG; McCall JT; Ahrenholz DH; Solem LD; McClain CJ
    Surgery; 1987 Jan; 101(1):40-3. PubMed ID: 3798326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic absorption of sulphadiazine, silver sulphadiazine and sodium sulphadiazine through human burn wounds.
    Aoyama H; Yokoo K; Fujii K
    Burns; 1990 Jun; 16(3):163-5. PubMed ID: 2383353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The human pharmacology of silver sulphadiazine (AgSD).
    Fox CL
    Burns Incl Therm Inj; 1985 Apr; 11(4):306-7. PubMed ID: 4005650
    [No Abstract]   [Full Text] [Related]  

  • 7. Acute leukopenia during topical burn therapy with silver sulfadiazine.
    Jarrett F; Ellerbe S; Demling R
    Am J Surg; 1978 Jun; 135(6):818-9. PubMed ID: 665909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A controlled study of the effects of silver sulfadiazine on white blood cell counts in burned children.
    Kiker RG; Carvajal HF; Mlcak RP; Larson DL
    J Trauma; 1977 Nov; 17(11):835-6. PubMed ID: 335078
    [No Abstract]   [Full Text] [Related]  

  • 9. Febrile reaction to silver sulphadiazine cream.
    Clarke SD; Gallur L; Threlfall GN
    Med J Aust; 1981 Aug; 2(4):208. PubMed ID: 7300733
    [No Abstract]   [Full Text] [Related]  

  • 10. Electron-microscopic observation on silver deposition in burn wounds treated with silver sulphadiazine cream.
    Akahane T; Tsukada S
    Burns Incl Therm Inj; 1982 Mar; 8(4):271-3. PubMed ID: 7066725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silver sulfadiazine: an antibacterial agent for topical use in burns. A review of the literature.
    Hoffmann S
    Scand J Plast Reconstr Surg; 1984; 18(1):119-26. PubMed ID: 6377481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective study of side effects associated with the use of silver sulfadiazine in severely burned patients.
    Kulick MI; Wong R; Okarma TB; Falces E; Berkowitz RL
    Ann Plast Surg; 1985 May; 14(5):407-19. PubMed ID: 4083697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transient leukopenia associated with topical silver sulfadiazine in burn therapy.
    Gbaanador GB; Policastro AJ; Durfee D; Bleicher JN
    Nebr Med J; 1987 Mar; 72(3):83-5. PubMed ID: 3561596
    [No Abstract]   [Full Text] [Related]  

  • 14. Tissue deposition of silver following topical use of silver sulphadiazine in extensive burns.
    Wang XW; Wang NZ; Zhang OZ; Zapata-Sirvent RL; Davies JW
    Burns Incl Therm Inj; 1985 Feb; 11(3):197-201. PubMed ID: 3986644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leukopenia in acute thermal injury: evidence against topical silver sulfadiazine as the causative agent.
    Thomson PD; Moore NP; Rice TL; Prasad JK
    J Burn Care Rehabil; 1989; 10(5):418-20. PubMed ID: 2793919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined use of topical cyclosporin A and silver sulphadiazine on allografts infected with Pseudomonas in burned rats.
    Lai CS; Miskell P; Gonce SJ; Alexander JW; Babcock GF
    Burns Incl Therm Inj; 1987 Jun; 13(3):181-4. PubMed ID: 3111646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of silver sulphadiazine 1 per cent, silver sulphadiazine 1 per cent plus chlorhexidine digluconate 0.2 per cent and mafenide acetate 8.5 per cent for topical antibacterial effect in infected full skin thickness rat burn wounds.
    Gray JH; Henry DA; Forbes M; Germann E; Roberts FJ; Snelling CF
    Burns; 1991 Feb; 17(1):37-40. PubMed ID: 2031672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute leukopenia associated with silver sulfadiazine therapy.
    Valente P; Axelrod JL
    J Trauma; 1978 Feb; 18(2):146-7. PubMed ID: 633424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allergic contact dermatitis to silver in a patient treated with silver sulphadiazine after a burn.
    García AA; Rodríguez Martín AM; Serra Baldrich E; Manubens Mercade E; Puig Sanz L
    J Eur Acad Dermatol Venereol; 2016 Feb; 30(2):365-6. PubMed ID: 25338976
    [No Abstract]   [Full Text] [Related]  

  • 20. Long-term experience with 1 per cent topical silver sulphadiazine cream in the management of burn wounds.
    Sawhney CP; Sharma RK; Rao KR; Kaushish R
    Burns; 1989 Dec; 15(6):403-6. PubMed ID: 2516445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.